DelveInsight’s, Coronary Stents Pipeline Insight and Competitive Landscape, 2022 report provides comprehensive insights about 20+ companies and 20+ pipeline devices in the Coronary Stents pipeline landscape. Owing to the rise in the prevalence of coronary artery diseases (CAD), the coronary stents market is witnessing remarkable growth. Significant players are focusing on expanding their geographical reach, for dominating the current market.
Coronary Stents Overview
Coronary stents are small, wire, mesh tubes that help widen a clogged artery and restore adequate blood flow to the heart. During the procedure, the cardiologist place the stent over a thin, long tube with a balloon tip called a catheter and insert it into an artery in groin or arm. Once the stent reaches the clogged artery, the doctor will inflate the balloon to expand the stent. When the stent reaches the desired size to widen the clogged artery, the doctor will deflate and remove the balloon. The stent will stay in place permanently to help prop open the artery and decrease its chance of narrowing again. Over time, the inner lining of the artery will grow over the surface of the stent, making it a permanent part of the artery.
Do you know about Coronary Stents Pipeline Insights?
Major Coronary Stents Companies
- REVA Medical Inc
- Rontis AG
- S3V Vascular Technologies
- Sahajanand Medical Technologies Pvt Ltd
- Shanghai Bio-heart Biological Technology Co Ltd
- Stentys SA
- Svelte Medical Systems Inc
- Tepha Inc
- Terumo Corp
- TissueGen Inc
- TrendyMED Inc
- VasoTech Inc
- And several others
Coronary Stents Pipeline: Types
Bare-Metal Stents: Tt is tiny wire mesh tubes that help widen a clogged artery, but are not coated with a polymer or drugs to help prevent re-blockage of the artery. This type of stent may be used in patients who are allergic to either the polymer or drugs used in drug-eluting stents.
Drug-Eluting Stents: A drug-eluting stent is a bare-metal stent that has been coated with a polymer that gradually releases a drug over the time when re-blockage is most likely to happen. This helps reduce the chance of the artery becoming blocked again. There are two types of drug-eluting stents: Permanent Polymer Drug-Eluting Stent and Bioabsorbable Polymer Drug-Eluting Stent.
Coronary Stents Pipeline Report
According to the Centre for Disease Control and Prevention, about one-third of the population in the U.S. is obese. The change in lifestyle such as physical inactivity, smoking, drinking, and mistimed and unhealthy food habits are among the major reasons leading to health problems such as obesity, hypertension, arterial blockage, and others. Therefore, owning to all this, there is a significant rise in the pipeline of coronary stents recently.
Coronary Stents: Competitive Assessment
This segment of the coronary stents devices pipeline report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including the latest news and press releases. The report also provides list of major players involved in the pipeline product development.
- Product Type
The coronary stents is segmented on the basis of product – Bare Metal Stents (BMS), Drug Eluting Stents (DES) and Bioresorbable Vascular Scaffolds (BVS).
- Product Biomaterial
Coronary Stents can be divided based upon the biomaterials – Metallic (Cobalt Chromium (CoCr), Platinum Chromium (Pt-Cr), Stainless Steel, Nickel Titanium), Polymeric Biomaterial and Natural Biomaterial.
Coronary Stents: Competitive Benchmarking
This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.
The analysis is based on
- Brand Positioning of Leading companies
- Application
- Industry Collaborations
Get in-depth information on Coronary Stents Pipeline Companies
Table of content
1. Key Insights
2. Coronary Stents: Snapshot
3. Coronary Stents
4. Product Assessment
5. Competitive Benchmarking: By Company
6. Commercialization Activity
7. Regulatory
8. Reimbursement
9. Market Dynamics
10. DelveInsight’s Analytical Perspective
11. Conclusion
12. Appendix
13. Bibliography
14. DelveInsight Capabilities
15. Disclaimer
16. About DelveInsight
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/